154 related articles for article (PubMed ID: 19486467)
21. A liver slice culture-based ex vivo assay to predict the outcome of antiviral therapy for chronic hepatitis C.
Chang ML; Sung KF; Sheen IS; Lin SM; Yeh CT
J Viral Hepat; 2009 May; 16(5):359-66. PubMed ID: 19243501
[TBL] [Abstract][Full Text] [Related]
22. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
Asselah T; Bièche I; Paradis V; Bedossa P; Vidaud M; Marcellin P
Semin Liver Dis; 2007 Feb; 27(1):13-27. PubMed ID: 17295174
[TBL] [Abstract][Full Text] [Related]
23. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
Inglot M; Szymczak A; Gasiorowski J
Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
[TBL] [Abstract][Full Text] [Related]
24. [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C].
Makashova VV; Florianu AI
Ter Arkh; 2008; 80(11):7-10. PubMed ID: 19143182
[TBL] [Abstract][Full Text] [Related]
25. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
Grebely J; Raffa JD; Lai C; Krajden M; Kerr T; Fischer B; Tyndall MW
J Viral Hepat; 2009 May; 16(5):352-8. PubMed ID: 19226330
[TBL] [Abstract][Full Text] [Related]
26. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
27. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
[TBL] [Abstract][Full Text] [Related]
28. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
Fabrizi F; Lunghi G; Messa P; Martin P
J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
[TBL] [Abstract][Full Text] [Related]
29. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic hepatitis C in HIV-infected patients: from clinical trials to field practice.
Piroth L; Martha B; Minello A; Grappin M; Chavanet P
Scand J Infect Dis; 2008; 40(6-7):561-4. PubMed ID: 18584548
[TBL] [Abstract][Full Text] [Related]
31. Mathematical modeling of HCV infection and treatment.
Dahari H; Shudo E; Ribeiro RM; Perelson AS
Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Wedemeyer H; Schuller E; Schlaphoff V; Stauber RE; Wiegand J; Schiefke I; Firbas C; Jilma B; Thursz M; Zeuzem S; Hofmann WP; Hinrichsen H; Tauber E; Manns MP; Klade CS
Vaccine; 2009 Aug; 27(37):5142-51. PubMed ID: 19559112
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.
Freudenreich O; Gandhi RT; Walsh JP; Henderson DC; Goff DC
Psychosomatics; 2007; 48(5):405-11. PubMed ID: 17878499
[TBL] [Abstract][Full Text] [Related]
34. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
[TBL] [Abstract][Full Text] [Related]
35. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
[TBL] [Abstract][Full Text] [Related]
36. Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
Perut V; Labalette C; Sogni P; Ferrand I; Salmon-Céron D; Vidal-Trecan G
Drug Alcohol Depend; 2009 Sep; 104(1-2):78-83. PubMed ID: 19464124
[TBL] [Abstract][Full Text] [Related]
37. Management of patients co-infected with HBV and HCV.
Coffin CS; Terrault NA
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795
[TBL] [Abstract][Full Text] [Related]
38. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C and renal transplantation: a review on historical aspects and current issues.
Moghaddam SM; Alavian SM; Kermani NA
Rev Med Virol; 2008; 18(6):375-86. PubMed ID: 18702126
[TBL] [Abstract][Full Text] [Related]
40. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
McDonald SA; Hutchinson SJ; Innes HA; Allen S; Bramley P; Bhattacharyya D; Carman W; Dillon JF; Fox R; Fraser A; Goldberg DJ; Kennedy N; Mills PR; Morris J; Stanley AJ; Wilks D; Hayes PC
J Viral Hepat; 2014 May; 21(5):366-76. PubMed ID: 24716639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
